OPTIMA

OPTIMA

„Optimal treatment for patients with solid tumours in Europe through Artificial intelligence“ – the aim of OPTIMA is to establish federated and centralised access to a variety of European health care datasets to help answer the important research questions in prostate, breast and lung cancer.

Additionally, comprehensive decision support tools will be developed, based on national and international guideline recommendations and statistical analysis, using artificial intelligence to support shared decision-making between physicians and patients.

Involved Institutions
More than 30 european partners, among others:
German Cancer Society (DKG)
European Association of Urology (EAU)
European Cancer Patient Coalition (ECPC)
European Respiratory Society (ERS)
Erasmus University Medical Center Rotterdam (EMC)
University College London / University College London Hospital (UCL/UCHL)
University of Oxford

Funding
European Union
Innovative Medicines Initiative (IMI)

Duration
October 2021 – September 2026

Publications
see publications

Website
www.optima-oncology.eu

Contact
PD Dr. rer. medic. Christoph Kowalski
Dr. med. Nora Tabea Sibert